Table 1 Clinical and histopathological data from oesophageal adenocarcinoma patients
Characteristics | Patient Numbers |
|---|---|
Gender | |
Male | 115 (79.9%) |
Female | 29 (20.1%) |
Age | |
< 60 years old | 41 (28.4%) |
60-69 years old | 70 (48.6%) |
≥70 years old | 33 (22.9%) |
Differentiation (n=2 unknown) | |
Well | 6 (4.2%) |
Moderate | 53 (37.3%) |
Poor | 83 (58.5%) |
Tumour T histological staging | |
T I | 17 (11.8%) |
T II | 27 (18.8%) |
T III | 95 (66%) |
T IV | 5 (3.4%) |
Tumour T clinical staging (n=12 unknown) | |
T I | 3 (2.1%) |
T II | 11 (7.6%) |
T III | 116 (80.6%) |
T IV | 2 (1.4%) |
Lymphovascular invasion | |
Negative | 46 (54.8%) |
Positive | 38 (45.2%) |
Tumour Recurrence | |
Negative | 65 (45.1%) |
Positive | 79 (54.9%) |
Mandard classification (n=8 unknown) | |
Response | 10 (7%) |
No response | 126 (87.5%) |
Tumour N stage (n=31 unknown) | |
N stage 0 | 55 (38.2%) |
N stage 1 | 28 (19.4%) |
N stage II | 30 (20.8%) |